agilon health, inc. 8-K

What Happened
agilon health, inc. (AGL) filed an 8-K on March 30, 2026, reporting that it effected a 1-for-25 reverse split of its common stock. The company filed a Certificate of Amendment with the Delaware Secretary of State, and the reverse stock split became effective at 4:36 p.m. Eastern Time on March 30, 2026. This action follows stockholder approval at the company’s March 17, 2026 Special Meeting and the Board’s exercise of its previously authorized discretion on the split ratio.

Key Details

• Ratio: 1-for-25 reverse stock split (each 25 pre-split shares → 1 post-split share).
• Effective time and trading: Certificate effective 4:36 p.m. ET on March 30, 2026; NYSE trading will be split-adjusted at market open on March 31, 2026 under the existing ticker “AGL.”
• Fractions & cash: No fractional shares will be issued; holders entitled to fractions will receive cash in lieu.
• Equity adjustments: Proportional adjustments made to shares available under equity incentive plans, and to exercise prices and shares issuable under outstanding options and other equity awards.
• Other corporate terms: The number of authorized shares and par value were not changed. New CUSIP for post-split common stock: 00857U 206.

Why It Matters
A reverse stock split reduces the number of outstanding shares and increases the per-share price proportionally; it does not change shareholders’ proportional ownership (aside from cash-outs for fractional shares). For investors, the key near-term effects are the new per-share basis and the split-adjusted trading on the NYSE starting March 31, 2026, plus adjusted option and equity award amounts and exercise prices. The filing documents the corporate steps taken to implement the split and the administrative details investors need for recordkeeping and trading.